Clinical Trials Sponsored by Lundbech Foundation

Total 16145 results

H. Lundbeck A/S

Completed

Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder

Major Depressive Disorder
H. Lundbeck A/S

Completed

Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients

Major Depressive Disorder
H. Lundbeck A/S

Completed

Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea

Parkinson's Disease
H. Lundbeck A/S

Completed

Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls

Depression

United Kingdom
H. Lundbeck A/S

Completed

Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies

Dementia With Lewy Bodies | Parkinson's Disease Dementia

Germany
H. Lundbeck A/S

Completed

Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence (SENSE)

Alcohol Dependence

Poland, Russian Federation, Ukraine, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Slovakia, United Kingdom
H. Lundbeck A/S

Completed

Efficacy of Nalmefene in Patients With Alcohol Dependence (ESENSE1)

Alcohol Dependence

Austria, Finland, Germany, Sweden
H. Lundbeck A/S

Terminated

Efficacy of Bifeprunox in Patients With Schizophrenia

Schizophrenia

India, Indonesia, Korea, Republic of, Malaysia, Philippines, Poland, Ukraine
H. Lundbeck A/S

Terminated

Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression

Depression in Patients With Bipolar Disorder

Austria, Philippines, Australia, Belgium, Bulgaria, Canada, France, Germany, Korea, Republic of, Lithuania, Malaysia, Poland, Romania, Slovakia, Sweden, Taiwan, Ukraine, United Kingdom
H. Lundbeck A/S

Terminated

Efficacy of Bifeprunox in Patients With Schizophrenia

Schizophrenia

Bulgaria, China, Greece, Romania, Russian Federation, Taiwan, Thailand, Ukraine
H. Lundbeck A/S

Completed

A Study of Gaboxadol in Primary Insomnia

Primary Insomnia
Mental Health Services in the Capital Region, Denmark
Lundbeck Foundation; Jascha Fonden

Completed

Neurofeedback as a Treatment for Trauma-affected Refugees

Post Traumatic Stress Disorder

Denmark
University of Southern Denmark
Lundbeck Foundation; IMK Almene Fond; Dansk Kiropraktor Fond

Completed

Skeletal Muscle Contractility, Self-reported Pain and Tissue Sensitivity in Females With Neck/Shoulder Pain and Trapezius MFTrPs

Myofascial Pain Syndrome

Denmark
Aarhus University Hospital
University of Aarhus; ALK-Abelló A/S; Lundbeck Foundation

Completed

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

Allergic Rhinoconjunctivitis
Odense University Hospital
University of Southern Denmark; Lundbeck Foundation; Else Poulsen Mindelegat

Unknown

Prevention of Decompensation in Liver Cirrhosis

Ascites | Alcoholic Liver Cirrhosis

Denmark
Glostrup University Hospital, Copenhagen
Bispebjerg Hospital; Lundbeck Foundation; University Hospital, Gentofte, Copenhagen and other collaborators

Completed

Effect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance

Migraine Without Aura

Denmark
Rigshospitalet, Denmark
The Lundbeck Foundation Centre for Fast-track Hip and Knee Arthroplasty

Completed

Safety Study of High-dose Methylprednisolone in Fast-track Total Knee Arthroplasty

Infection of Total Knee Joint Prosthesis

Denmark
Mental Health Services in the Capital Region, Denmark
University of Copenhagen; Lundbeck Foundation

Completed

Efficacy of Dialectical Behavior Therapy Versus CAMS-informed Supportive Psychotherapy on Self Harming Behavior (DiaS)

Suicide | Borderline Personality Disorder

Denmark
Lars Vedel Kessing
Lundbeck Foundation; Mental Health Services in the Capital Region, Denmark

Completed

Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders (PreTEC-EPO)

Cognitive Impairment | Bipolar Disorder | Unipolar Depression

Denmark
Rigshospitalet, Denmark
Lundbeck Foundation; Filadelfia Epilepsy Hospital; Lennart Grams Mindefond, Danish...

Completed

Clinical Utility of ESI in Presurgical Evaluation of Patients With Epilepsy (CUESIPE)

Surgery | Refractory Epilepsy | Electroencephalography | Brain Imaging

Denmark
Bispebjerg Hospital
Danish Cancer Society; The Novo Nordic Foundation; Lundbeck Foundation; Sygekassernes... and other collaborators

Completed

Family and Coping Oriented Palliative Homecare Nursing Aimed at Advanced Cancer Patients (FamCope)

Advanced Cancer

Denmark
University of Bordeaux
Lundbeck France

Completed

Use of Selincro and Impact on Usual Practice (USE-PACT)

Alcohol Dependence

France
Boston Children's Hospital
Lundbeck LLC

Completed

Electrical Status Epilepticus in Sleep: Response of Neuropsychological Deficits and Epileptiform Activity to Clobazam Treatment (ESES-Clobazam)

Electrical Status Epilepticus in Sleep

United States
Takeda
H. Lundbeck A/S

Completed

Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States, Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine, United Kingdom
Ohio State University
Lundbeck LLC

Completed

Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease

Huntington's Disease

United States
Takeda
H. Lundbeck A/S

Completed

Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.

Generalized Anxiety Disorder

Ukraine, Germany, Romania, Russian Federation, Lithuania, Latvia, Estonia, Poland
Takeda
H. Lundbeck A/S

Completed

Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Major Depressive Disorder

United States, France, United Kingdom, Germany, Malaysia, Serbia, South Africa, Ukraine, Taiwan, Korea, Republic of, Russian Federation, Lithuania, Latvia, Croatia, Australia, Netherlands, Poland
Takeda
H. Lundbeck A/S

Completed

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

Major Depressive Disorder

United States, Mexico, Canada
Qualissima
H. Lundbeck A/S

Terminated

Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease (ACTOR)

Early-stage Parkinson's Disease
Sheba Medical Center
Lundbeck Israel

Unknown

Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder

Major Depressive Disorder

Israel
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Korea, Republic of, United States, Hungary, Poland, Spain, Serbia, Estonia, Bulgaria, Mexico, Russian Federation, Ukraine, Canada, Colombia, France, Germany, Israel, Italy, Latvia, South Africa
H. Lundbeck A/S
Takeda

Completed

Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder

Depressive Disorder, Major

Finland, Estonia
Takeda
H. Lundbeck A/S

Completed

Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
Takeda
H. Lundbeck A/S

Completed

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Takeda
H. Lundbeck A/S

Completed

Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Major Depressive Disorder

France, Ukraine, Germany, Malaysia, South Africa, Korea, Republic of, Russian Federation, Czech Republic, Lithuania, United Kingdom, Latvia, Australia, Netherlands, Poland, Taiwan
Takeda
H. Lundbeck A/S

Completed

An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
University of Aarhus
University of Copenhagen; University of Ghana; Lundbeck Foundation; Augustinus... and other collaborators

Completed

Reduction of Adverse Pregnancy Outcomes With a Smartphone Application in Ghana

Infant Mortality | Postpartum Hemorrhage | Stillbirth | Midwifery | Delivery, Obstetric

Ghana
Christina Kruuse
University of Copenhagen; The Novo Nordic Foundation; Lundbeck Foundation; Danish...

Recruiting

Patient-tailored Transcranial Direct Current Stimulation to Improve Stroke Rehabilitation (PRACTISE)

Ischemic Stroke | Upper Extremity Hemiparesis

Denmark
Ib Christian Bygbjerg
Rigshospitalet, Denmark; University of Copenhagen; Lundbeck Foundation; Free University... and other collaborators

Completed

The PartoMa Project: For Improving Monitoring, Action and Triage During Labour (PartoMa)

Obstetric Labor Complications | Maternal Death | Stillbirth

Tanzania
Bjorn H. Ebdrup
University of Copenhagen; Lundbeck Foundation; Danish Research Centre for Magnetic...

Recruiting

Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis (AMEND)

Psychosis | Negative Symptoms With Primary Psychotic Disorder

Denmark
Bispebjerg Hospital
H. Lundbeck A/S; The Danish Medical Research Council; Danish Heart Foundation

Unknown

DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome

Depression

Denmark
Advocate Health Care
Takeda; Lundbeck LLC

Completed

Use of a Digitally Enabled App With Clinical Team Interface in the Management of Depression

Major Depressive Disorder

United States
New York Medical College
Lundbeck LLC

Active, not recruiting

Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)

Postural Tachycardia Syndrome (POTS) | Fainting | Vasovagal Syncope (VVS)

United States
The Cooper Health System
Lundbeck LLC

Terminated

Clobazam Use in Epilepsia Partialis Continua - Pilot Study

Epilepsy | Epilepsia Partialis Continua | Kojewnikov's Epilepsy

United States
H. Lundbeck A/S
Solvay Pharmaceuticals

Terminated

Bifeprunox Extension to Extension Study in Patients With Schizophrenia

Schizophrenia

Italy
Peking University
H. Lundbeck A/S

Unknown

Memantine on Aggression and Agitation of Alzheimer's Disease (AD)

Alzheimer's Disease

China
Queen's University
H. Lundbeck A/S

Completed

Specific Effects of Escitalopram on Neuroendocrine Response

Healthy

Canada
BeerYaakov Mental Health Center
Lundbeck Israel

Completed

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

Schizophrenia

Israel
H. Lundbeck A/S
ICON plc

Completed

Vortioxetine in Patients With Depression and Early Dementia (MEMORY)

Dementia | Major Depressive Disorder

Korea, Republic of, Spain, Poland, Estonia, France, Italy

Clinical Trials Sponsored by Lundbech Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations